Independent public relations agency, DEC PR, has been appointed by Bayer Consumer Health Australia to undertake a series of PR campaigns across its brand portfolio.
The Agency has begun work leading a product launch campaign for the new Bepanthen Tattoo product, as well as an equity campaign for women’s intimate health brand, Canesten.
Matteo Piovan, Marketing Manager, Derm & Pain Portfolio, Bayer Consumer Health Australia, says: “We were impressed with DEC PR’s ability to deliver impact against campaign objectives while ensuring all stakeholders – from consumers, to retail partners and healthcare KOLs – are brought along on the journey.
For both the Bepanthen Tattoo and Canesten women’s intimate health campaigns, we required a team that was equally passionate and capable to deliver meaningful brand results and push the creative boundaries. DEC PR is doing just that.”
Sarah-Ann Taylor, Group Client Director, DEC PR says: “The DEC PR team is extremely passionate about the healthcare sector and so winning these public relations pitches for Bayer has been a highlight of this year. The team at Bayer has charged and empowered us to think outside the box and we are collaborating closely with them. We’re looking forward to launching the initial campaigns mid-year.”
Bepanthen Tattoo and the Canesten women’s intimate health portfolio join a growing portfolio of consumer healthcare clients at DEC PR.
